Substance Withdrawal Syndrome. (Record no. 61061)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 08157nam a22004933i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3020822 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124142.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2009 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781617285868 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781606929513 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3020822 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3020822 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10680960 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)923664487 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM302.6 -- .S83 2009eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615/.704 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rees, Janet P. |
| 245 10 - TITLE STATEMENT | |
| Title | Substance Withdrawal Syndrome. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | New York : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2009. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2009. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (260 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Drug Transit and Distribution, Interception and Control Series |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- SUBSTANCE WITHDRAWALSYNDROME -- Contents -- Preface -- Psychotropic Analgesic Nitrous Oxide[PAN] for Substance AbuseWithdrawal: Current Status -- Abstract -- Introduction - Distinguishing betweenPsychotropic Analgesic Nitrous Oxide andAnaesthetic Nitrous Oxide -- How PAN Ameliorates Substance AbuseWithdrawal States -- PAN for Treating Alcohol Withdrawal States -- Alcohol Withdrawal States -- Double-Blind, Randomised Trials with PAN versus A Benzodiazepine -- PAN for Treating Other Substances of AbuseApart from Alcohol -- Opioids -- Cocaine -- Nicotine -- Cannabis -- Polydrug Abuse -- Anti-Craving Properties of PAN -- Alcohol -- Cannabis -- Nicotine -- Current Status of PAN for Substance AbuseWithdrawal -- Credibility Gap -- Lack of Commercial Interest in PAN -- Conclusion -- Acknowledgements -- References -- Selective Serotonin ReuptakeInhibitors Withdrawal Syndromes: NewInsights into Pathophysiology andTreatment -- Abstract -- Characteristics of Discontinuation Syndromes -- The Oppositional Tolerance Model -- Long-Term Outcome of Major Depression Treated by PharmacologicalMeans -- Paradoxical Effects of Antidepressant Drugs -- Antidepressant-Induced Switching in Bipolar Disorder -- Tolerance to Antidepressant Drugs -- Antidepressant-Induced Switching in Bipolar Disorder -- Tolerance to Antidepressant Drugs -- Resistance to Antidepressant Drugs -- The Sequenced Treatment Alternatives to RelieveDepression Study (STAR*D) -- Pathophysiological Interactions -- Interaction between Different Types of Serotonin Receptors -- Interactions between Different Neurotransmitters -- Interaction between Neurotransmitter Balance and the Hypothalamic-Pituitary-Adrenal Axis -- Cross-Sensitization with Behavioral and Cognitive Phenomena -- Conclusions -- References. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Benzodiazepine Withdrawal Syndromeand Strategies for DiscontinuingBenzodiazepine Use: AppropriateTreatment with SSRIs and SNRIs -- Abstract -- Introduction -- Benzodiazepine Issues in Japan -- Study 1: Benzodiazepine Prescription in a Hospital -- Implications of study 1 -- Strategies for Benzodiazepine Withdrawal -- Study 2: Benzodiazepine Withdrawal Using SSRI -- Implications of Study 2 -- The Possibility of SSRI Withdrawal Syndrome -- Conclusions -- References -- Carisoprodol Withdrawal Syndrome -- Abstract -- Introduction -- Pharmacological Properites and Metabolism ofCarisoprodol -- Abuse Potential of Carisoprodol -- Early Case Reports of Carisoprodol Abuse -- Other Aspects of Carisoprodol Abuse -- Evidence of Increasing Abuse of Carisprodol -- Carisoprodol Withdrawal Syndrome -- Evidence of Withdrawal Symptoms from Early Case Reports -- Cases of Carisoprodol Withdrawal Syndrome -- Proposed Mechanism for CarisoprodolWithdrawal Symptoms -- Clinical Implications -- Controlled Substances Issues -- References -- Is Aspirin Withdrawal Detrimental forPatients with or at Risk for CoronaryArtery Disease? A Meta-Analysis -- Abstract -- Introduction -- Epidemiology of Coronary Artery Disease -- Risk-benefit balance of aspirin -- Potential hazards of aspirin withdrawal in patients with or at risk forcoronary artery disease -- Rationale and Aim of the Present Study -- Methods -- Search Strategy -- Study Selection -- Data Abstraction -- Internal Validity and Quality Appraisal -- Data Analysis and Synthesis -- Results -- Characteristics of Included Studies -- Characteristics of Excluded Studies -- Meta-Analysis -- Additional Analyses -- Discussion -- Current Clinical and Research Context -- Contributions of the Present Study -- Proposal for Management of Patients on Aspirin Undergoing InvasiveProcedures -- Limitations of the Present Study -- Conclusion. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Acknowledgements -- Appendix -- References -- Changes Observed in Circulatory andAlimentary Systems in AlcoholDependent Patients during theWithdrawal Period -- Abstract -- Introduction -- Consequences of Alcohol Abuse and Withdrawalin the Gastrointestinal Tract -- Cardiovascular Effect of Alcohol Withdrawal -- Main Points of Author's Reasearch Results -- Introduction -- Plasma Lipids -- Platelets -- Plasma Blood Coagulation System -- Plasma Blood Fibrinolysis System -- Nitric Oxide -- Tumor Necrosis Factor Type Alpha (TNF-alpha) -- Blood Pressure -- Heart Rate Variability -- Physical Activity -- Glucose Tolerance -- Sex Hormones -- Main Points of Authors' Studies Results -- Introduction -- The Upper Digestive Tract Morphological and Functional Status -- Esophageal Lesions -- Gastritis Features -- Gastric and Esophageal 24-hours pH-metry. Esophageal 24-hoursManometry -- Tumor Necrosis Factor Alpha (TNF-alpha) Concentration in the Aspect ofLiver Injury Pathogenesis -- References -- The Effects of Acute, Chronic andWithdrawal from Chronic Ethanol onEmotional Learning* -- Abstract -- Introduction -- Brain Areas Involved in the Modulation ofLearning by Ethanol -- Effects of Acute Ethanol on Aversive Learning -- Standard Fear Conditioning -- Trace Fear Conditioning -- Passive Avoidance -- Factors Influencing the Effects of Ethanol on Aversive Learning -- Summary -- Effects of Chronic Ethanol and Withdrawal fromChronic Ethanol on Aversive Learning -- Effects of Chronic Ethanol on Aversive Learning -- Passive Avoidance -- Fear Conditioning -- Effects of Withdrawal from Chronic Ethanol onAversive Learning -- Chronic Intermittent Ethanol and Withdrawal -- Fear Conditioning -- Passive Avoidance -- Effects of Single Withdrawal from Chronic Ethanol -- Passive Avoidance -- Post-withdrawal Effects of Ethanol on AversiveLearning -- Fear Conditioning. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Passive Avoidance -- Cellular Processes Underlying Ethanol-InducedMemory Deficits -- Conclusions -- References -- Topographic Brain Mapping of CaffeineUse and Caffeine Withdrawal -- Abstract -- Introduction -- The EEG during Caffeine Exposure -- The Quantitative EEG during Caffeine Withdrawal -- Other EEG Occurrences during CaffeineWithdrawal -- Cognitive Evoked Potential and CaffeineWithdrawal -- Significance of Electrophysiological Effects ofCaffeine Exposure and Withdrawal -- Conclusions -- References -- Craving, Leptin and MetabolicAssessment in Subjects with CocaineAbuse Dependence:Results from an Original Study -- Abstract -- Introduction -- Methods -- Procedure -- Leptin Dosage Procedure -- Data Analysis -- Results -- Conclusion -- Acknowledgments -- References -- Index. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug withdrawal symptoms. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Woodhouse, Olivia B. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Rees, Janet P. |
| Title | Substance Withdrawal Syndrome |
| Place, publisher, and date of publication | New York : Nova Science Publishers, Incorporated,c2009 |
| International Standard Book Number | 9781606929513 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Drug Transit and Distribution, Interception and Control Series |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020822">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020822</a> |
| Public note | Click to View |
No items available.